265 related articles for article (PubMed ID: 15183620)
1. Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial.
Alloueche A; Bailey W; Barton S; Bwika J; Chimpeni P; Falade CO; Fehintola FA; Horton J; Jaffar S; Kanyok T; Kremsner PG; Kublin JG; Lang T; Missinou MA; Mkandala C; Oduola AM; Premji Z; Robertson L; Sowunmi A; Ward SA; Winstanley PA
Lancet; 2004 Jun; 363(9424):1843-8. PubMed ID: 15183620
[TBL] [Abstract][Full Text] [Related]
2. Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial.
Sulo J; Chimpeni P; Hatcher J; Kublin JG; Plowe CV; Molyneux ME; Marsh K; Taylor TE; Watkins WM; Winstanley PA
Lancet; 2002 Oct; 360(9340):1136-43. PubMed ID: 12387962
[TBL] [Abstract][Full Text] [Related]
3. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
Gosling RD; Gesase S; Mosha JF; Carneiro I; Hashim R; Lemnge M; Mosha FW; Greenwood B; Chandramohan D
Lancet; 2009 Oct; 374(9700):1521-32. PubMed ID: 19765815
[TBL] [Abstract][Full Text] [Related]
4. Risks of Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficient Infants Exposed to Chlorproguanil-Dapsone, Mefloquine and Sulfadoxine-Pyrimethamine as Part of Intermittent Presumptive Treatment of Malaria in Infants.
Poirot E; Vittinghoff E; Ishengoma D; Alifrangis M; Carneiro I; Hashim R; Baraka V; Mosha J; Gesase S; Chandramohan D; Gosling R
PLoS One; 2015; 10(11):e0142414. PubMed ID: 26599634
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial.
von Seidlein L; Milligan P; Pinder M; Bojang K; Anyalebechi C; Gosling R; Coleman R; Ude JI; Sadiq A; Duraisingh M; Warhurst D; Alloueche A; Targett G; McAdam K; Greenwood B; Walraven G; Olliaro P; Doherty T
Lancet; 2000 Jan; 355(9201):352-7. PubMed ID: 10665554
[TBL] [Abstract][Full Text] [Related]
6. Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania.
Mutabingwa T; Nzila A; Mberu E; Nduati E; Winstanley P; Hills E; Watkins W
Lancet; 2001 Oct; 358(9289):1218-23. PubMed ID: 11675058
[TBL] [Abstract][Full Text] [Related]
7. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria.
Kublin JG; Dzinjalamala FK; Kamwendo DD; Malkin EM; Cortese JF; Martino LM; Mukadam RA; Rogerson SJ; Lescano AG; Molyneux ME; Winstanley PA; Chimpeni P; Taylor TE; Plowe CV
J Infect Dis; 2002 Feb; 185(3):380-8. PubMed ID: 11807721
[TBL] [Abstract][Full Text] [Related]
8. Chlorproguanil-dapsone for malaria in Africa.
Looareesuwan S; Imwong M; Wilairatana P
Lancet; 2004 Jun; 363(9424):1838-9. PubMed ID: 15183616
[No Abstract] [Full Text] [Related]
9. Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial.
Mutabingwa TK; Anthony D; Heller A; Hallett R; Ahmed J; Drakeley C; Greenwood BM; Whitty CJ
Lancet; 2005 Apr 23-29; 365(9469):1474-80. PubMed ID: 15850631
[TBL] [Abstract][Full Text] [Related]
10. Chlorproguanil-dapsone: effective treatment for uncomplicated falciparum malaria.
Amukoye E; Winstanley PA; Watkins WM; Snow RW; Hatcher J; Mosobo M; Ngumbao E; Lowe B; Ton M; Minyiri G; Marsh K
Antimicrob Agents Chemother; 1997 Oct; 41(10):2261-4. PubMed ID: 9333058
[TBL] [Abstract][Full Text] [Related]
11. Short report: comparison of chlorproguanil-dapsone with a combination of sulfadoxine-pyrimethamine and chloroquine in children with malaria in northcentral Nigeria.
Ogunfowokan O; Dankyau M; Madaki AJ; Thacher TD
Am J Trop Med Hyg; 2009 Feb; 80(2):199-201. PubMed ID: 19190213
[TBL] [Abstract][Full Text] [Related]
12. A randomised trial to assess the efficacy and safety of chlorproguanil/dapsone + artesunate for the treatment of uncomplicated Plasmodium falciparum malaria.
Fanello CI; Karema C; Ngamije D; Uwimana A; Ndahindwa V; Van Overmeir C; Van Doren W; Curtis J; D'Alessandro U
Trans R Soc Trop Med Hyg; 2008 May; 102(5):412-20. PubMed ID: 18328518
[TBL] [Abstract][Full Text] [Related]
13. Combination treatments for uncomplicated falciparum malaria in Kampala, Uganda: randomised clinical trial.
Staedke SG; Mpimbaza A; Kamya MR; Nzarubara BK; Dorsey G; Rosenthal PJ
Lancet; 2004 Nov 27-Dec 3; 364(9449):1950-7. PubMed ID: 15567011
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial of artesunate+amodiaquine, sulfadoxine-pyrimethamine+amodiaquine, chlorproguanal-dapsone and SP for malaria in pregnancy in Tanzania.
Mutabingwa TK; Muze K; Ord R; Briceño M; Greenwood BM; Drakeley C; Whitty CJ
PLoS One; 2009; 4(4):e5138. PubMed ID: 19352498
[TBL] [Abstract][Full Text] [Related]
15. High risk of severe anaemia after chlorproguanil-dapsone+artesunate antimalarial treatment in patients with G6PD (A-) deficiency.
Fanello CI; Karema C; Avellino P; Bancone G; Uwimana A; Lee SJ; d'Alessandro U; Modiano D
PLoS One; 2008; 3(12):e4031. PubMed ID: 19112496
[TBL] [Abstract][Full Text] [Related]
16. Sulfadoxine-pyrimethamine, chlorproguanil-dapsone, or chloroquine for the treatment of Plasmodium vivax malaria in Afghanistan and Pakistan: a randomized controlled trial.
Leslie T; Mayan MI; Hasan MA; Safi MH; Klinkenberg E; Whitty CJ; Rowland M
JAMA; 2007 May; 297(20):2201-9. PubMed ID: 17519409
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon.
Basco LK; Same-Ekobo A; Ngane VF; Ndounga M; Metoh T; Ringwald P; Soula G
Bull World Health Organ; 2002; 80(7):538-45. PubMed ID: 12163917
[TBL] [Abstract][Full Text] [Related]
18. Improved efficacy with amodiaquine instead of chloroquine in sulfadoxine/pyrimethamine combination treatment of falciparum malaria in Uganda: experience with fixed-dose formulation.
Obua C; Gustafsson LL; Aguttu C; Anokbonggo WW; Ogwal-Okeng JW; Chiria J; Hellgren U
Acta Trop; 2006 Nov; 100(1-2):142-50. PubMed ID: 17113554
[TBL] [Abstract][Full Text] [Related]
19. Patterns of resistance and DHFR/DHPS genotypes of Plasmodium falciparum in rural Tanzania prior to the adoption of sulfadoxine-pyrimethamine as first-line treatment.
Eriksen J; Mwankusye S; Mduma S; Kitua A; Swedberg G; Tomson G; Gustafsson LL; Warsame M
Trans R Soc Trop Med Hyg; 2004 Jun; 98(6):347-53. PubMed ID: 15099990
[TBL] [Abstract][Full Text] [Related]
20. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
